PsychedelicNewsBreaks – Pure Extract Technologies Inc. Leveraging Growing Acceptance of ‘Nature’s Miniature Pharmaceutical Factories’

Pure Extract, a private, plant-based extraction company, is leveraging growing acceptance by mainstream science and the general public to further develop and commercialize functional and medicinal mushroom products on a global scale. World-renowned mycologist Paul Stamets describes mushrooms as “nature’s miniature pharmaceutical factories” (https://ibn.fm/wbYSa). Studied extensively for their various health benefits, current research suggests different varieties of mushrooms may help to improve memory (https://ibn.fm/KUHQ3), mental cognition (https://ibn.fm/dNuo4) and to alleviate the symptoms of depression (https://ibn.fm/YCMQK). Further, “Psychedelic” varieties such as psilocybin – or “magic mushrooms” – are increasingly being studied for possible medical benefits in treating depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease and addiction. A recent article discusses the company’s positioning in the emerging industry. The piece reads, “Pure Extracts has a solid position in the industry to partner with organizations in the sourcing, production and development of functional mushroom products and to advance its mushroom extraction techniques in order to produce consistent, ultra-pure, compounds. Besides being licensed by Health Canada to buy, sell and produce cannabis products, the Company’s 10,000 square foot facility is designed for EU-GMP certification, which will allow Pure Extracts to sell its products throughout the world.”

To view the full article, visit https://ibn.fm/F2uxM

About Pure Extracts Technologies Inc.

Pure Extracts is positioned to enter the commercial cannabis sector, as well as a new vertical in functional mushrooms, as an experienced producer. Led by a team of qualified experts and providing cutting-edge CO2 extraction technology, the company is set up for long-term strategic distribution and product innovation. For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.